Article Versions Notes

Luu L, Bah GS, Okah-Nnane NH, Hartley CS, Glover AF, Walsh TR, Lian L-Y, Zhan B, Bottazzi ME, Abraham D, et al. Co-Administration of Adjuvanted Recombinant Ov-103 and Ov-RAL-2 Vaccines Confer Protection against Natural Challenge in A Bovine Onchocerca ochengi Infection Model of Human Onchocerciasis. Vaccines. 2022; 10(6):861. https://doi.org/10.3390/vaccines10060861

Luu, Lisa, Germanus S. Bah, Ndode Herman Okah-Nnane, Catherine S. Hartley, Alexandra F. Glover, Tessa R. Walsh, Lu-Yun Lian, Bin Zhan, Maria Elena Bottazzi, David Abraham, and et al. 2022. "Co-Administration of Adjuvanted Recombinant Ov-103 and Ov-RAL-2 Vaccines Confer Protection against Natural Challenge in A Bovine Onchocerca ochengi Infection Model of Human Onchocerciasis" Vaccines 10, no. 6: 861. https://doi.org/10.3390/vaccines10060861

Luu, L., Bah, G. S., Okah-Nnane, N. H., Hartley, C. S., Glover, A. F., Walsh, T. R., Lian, L.-Y., Zhan, B., Bottazzi, M. E., Abraham, D., Petrovsky, N., Bayang, N., Tangwa, B., Ayiseh, R. B., Mbah, G. E., Ekale, D. D., Tanya, V. N., Lustigman, S., Makepeace, B. L., & Graham-Brown, J. (2022). Co-Administration of Adjuvanted Recombinant Ov-103 and Ov-RAL-2 Vaccines Confer Protection against Natural Challenge in A Bovine Onchocerca ochengi Infection Model of Human Onchocerciasis. Vaccines, 10(6), 861. https://doi.org/10.3390/vaccines10060861